IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wikberg-Matsson, A.
Right arrow Articles by Simonsen, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wikberg-Matsson, A.
Right arrow Articles by Simonsen, U.
(Investigative Ophthalmology and Visual Science. 2001;42:2049-2055.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Potent {alpha}2A-Adrenoceptor–Mediated Vasoconstriction by Brimonidine in Porcine Ciliary Arteries

Anna Wikberg-Matsson1,2 and Ulf Simonsen3

1 From the Department of Neuroscience, Ophthalmology, University Hospital, Uppsala, Sweden; the 2 Department of Neuroscience, Unit of Pharmacology, Uppsala University, Sweden; and the 3 Department of Pharmacology, University of Aarhus, Denmark.

PURPOSE. An investigation into whether {alpha}2-adrenoceptor agonists induce contractions in the porcine ciliary arteries and to characterize the functional receptor subtype mediating these responses.

METHODS. Isolated arteries from the intraocular part of the porcine ciliary artery were suspended in microvascular myographs for isometric tension recording. The segments were contracted with the {alpha}2-adrenoceptor agonists brimonidine, apraclonidine, and oxymetazoline. To determine which subtypes of the {alpha}2-adrenoceptor mediate this contraction, antagonists subselective for the different {alpha}2-adrenoceptors were added to the vessel bath before concentration–response curves for brimonidine were obtained. The following {alpha}2-adrenoceptor antagonists were applied: BRL44408 ({alpha}2A-selective), ARC239 ({alpha}2B- and {alpha}2C-selective), and prazosin ({alpha}2B- and {alpha}2C-selective).

RESULTS. The {alpha}2-adrenoceptor agonists induced vasoconstriction in the porcine ciliary artery with the following potency order (EC50) expressed in nanomolar: brimonidine 2.11, oxymetazoline 5.26, and apraclonidine 13.0. As a reference, noradrenaline was tested, and its EC50 was determined to be 247 nM in the ciliary artery. In the porcine ciliary arteries BRL44408, ARC239, and prazosin caused concentration-dependent and parallel rightward shifts of the concentration–response curves for brimonidine. Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies (pKB) for BRL44408 (7.8), ARC 239 (5.8) and for prazosin (6.0) suggesting the presence of functional {alpha}2A-adrenoceptors. Moreover, there was a good correlation of pKB with ligand-binding affinity (pKi) of the {alpha}2A-adrenoceptor in the porcine eye tissue.

CONCLUSIONS. The {alpha}2-adrenoceptor agonists brimonidine, apraclonidine, and oxymetazoline are potent vasoconstrictors in the porcine ciliary artery. In the present work, it was shown for the first time that the {alpha}2A-adrenoceptor subtype mediates this contraction.




This article has been cited by other articles:


Home page
IOVSHome page
M. Aihara, J. D. Lindsey, and R. N. Weinreb
Effect on Diurnal Intraocular Pressure Variation of Eliminating the {alpha}-2 Adrenergic Receptor Subtypes in the Mouse
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 929 - 933.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
G. Weigert, H. Resch, A. Luksch, H. A Reitsamer, G. Fuchsjager-Mayrl, L. Schmetterer, and G. Garhofer
Intravenous administration of clonidine reduces intraocular pressure and alters ocular blood flow
Br. J. Ophthalmol., October 1, 2007; 91(10): 1354 - 1358.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
G. Weigert, H. Resch, G. Garhofer, G. Fuchsjager-Mayrl, and L. Schmetterer
Effects of Topical Clonidine versus Brimonidine on Choroidal Blood Flow and Intraocular Pressure during Squatting
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4220 - 4225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology